Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $11.68 USD
Change Today +0.36 / 3.18%
Volume 343.7K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Philip W. Kantoff M.D.

Chief Clinical Research Officer and Member of Medical Advisory Committee,Tokai Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 75 board members in 6 different organizations across 7 different industries.

See Board Relationships


Dr. Philip W. Kantoff, M.D., serves as Scientific & Clinical Advisor at Metamark Genetics, Inc. Dr. Kantoff serves as Chief Clinical Research Officer of Tokai Pharmaceuticals, Inc. He has been Chief Clinical Research Officer at Dana-Farber Cancer Institute, Inc. since October 2006. He serves as Chief of Division of Solid Tumor Oncology and Leader of the Dana-Farber and Harvard Cancer Center Prostate Cancer Program. He joined Dana-Farber in 1987. He serves as Director ...

Read Full Background

Corporate Headquarters*

255 State Street
Boston, Massachusetts 02109

United States

Phone: 617-225-4305
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education 1979
Brown University Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TKAI:US $11.68 USD +0.36


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TOKAI PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at